These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1963150)

  • 1. Kappa opioid receptor-mediated depression of activity evoked in convergent dorsal horn cells by thermal and non-thermal noxious stimulation.
    Hernández A; Paeile C; Pérez H; Pelissier T; Soto-Moyano R
    Eur J Pharmacol; 1990 Sep; 186(2-3):323-5. PubMed ID: 1963150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
    Dong XW; Parsons CG; Headley PM
    Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons.
    Hylden JLK; Nahin RL; Traub RJ; Dubner R
    Pain; 1991 Feb; 44(2):187-193. PubMed ID: 1675783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a kappa-receptor agonist, U-50,488H, on the release of endogenous brain dopamine.
    Clow DW; Jhamandas K
    Can J Physiol Pharmacol; 1988 Feb; 66(2):128-33. PubMed ID: 2836044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro depressant effects of U-54494A, an anticonvulsant related to kappa opioids, in the hippocampus.
    Proietti ML; Scotti de Carolis A; Frank C; Zeng YC; Sagratella S
    Neuropharmacology; 1991 Jun; 30(6):637-42. PubMed ID: 1656303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
    Czlonkowski A; Millan MJ; Herz A
    Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
    [No Abstract]   [Full Text] [Related]  

  • 12. Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus.
    Parsons CG; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):523-32. PubMed ID: 2555011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
    Sullivan AF; Dickenson AH
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1119-25. PubMed ID: 2005577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu and kappa opioid modulation of olfactory bulb evoked potentials.
    Pérez H; Hernández A; Inostroza H
    Int J Neurosci; 1989 Dec; 49(3-4):329-32. PubMed ID: 2561634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of mu-, delta- and kappa-opiate receptor agonists on the bioelectrical activity of the viscerosomatic convergent neurons in the posterior horn of the spinal cord].
    Kasparov SA
    Eksp Klin Farmakol; 1993; 56(1):13-6. PubMed ID: 8391888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ethanol in an open field apparatus: modification by U50488H and WIN 44441-3.
    Pohorecky LA; Patel V; Roberts P
    Physiol Behav; 1989 Feb; 45(2):273-87. PubMed ID: 2547220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.